Leap Therapeutics News - LPTX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Leap Therapeutics Inc LPTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 1.42 1.35 1.4828 1.45 1.42 00:00:00
more quote information »

Recent News

Date Time Source Heading
3/23/202016:44EDGARStatement of Beneficial Ownership (sc 13d)
3/23/202016:38EDGARInitial Statement of Beneficial Ownership (3)
3/20/202008:18EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/19/202016:45EDGARStatement of Changes in Beneficial Ownership (4)
3/18/202017:24EDGARCurrent Report Filing (8-k)
3/18/202007:00PRNUSLeap Therapeutics Announces Executive Leadership Changes
3/16/202007:00PRNUSLeap Therapeutics Reports Fourth Quarter and Full Year 2019..
3/09/202009:14EDGARCurrent Report Filing (8-k)
3/04/202017:10EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202017:09EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202017:09EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202017:08EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202017:08EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202017:07EDGARStatement of Changes in Beneficial Ownership (4)
2/26/202007:00PRNUSLeap Therapeutics to Present at Cowen 40th Annual Health..
2/13/202016:47EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
2/10/202009:16EDGARProxy Statement (definitive) (def 14a)
2/07/202011:26EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202007:00PRNUSLeap Therapeutics to Present at 22nd Annual BIO CEO &..
1/28/202017:18EDGARProxy Statement - Notice of Shareholders Meeting..
1/23/202007:00PRNUSLeap Therapeutics Presents Updated Data at the ASCO 2020..
1/21/202017:04EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
1/07/202017:19EDGARCurrent Report Filing (8-k)
1/07/202016:05PRNUSLeap Therapeutics Announces Closing of Previously Announced..
1/03/202011:12DJNLeap Therapeutics Shares Jump 56% After Deal With BeiGene
1/03/202009:38DJNLeap Therapeutics Shares Up 62% Premarket on BeiGene Deal
1/03/202009:11EDGARCurrent Report Filing (8-k)
1/03/202008:53PRNUSLeap Therapeutics and BeiGene Announce Exclusive Option and..
11/22/201916:31EDGARCurrent Report Filing (8-k)
11/14/201907:16EDGARCurrent Report Filing (8-k)
11/14/201907:00PRNUSLeap Therapeutics Reports Third Quarter 2019 Financial..
11/14/201906:52EDGARQuarterly Report (10-q)
9/17/201907:16EDGARCurrent Report Filing (8-k)
9/17/201907:00PRNUSLeap Therapeutics to Present Updated Data for DKN-01..
9/04/201907:02PRNUSLeap Therapeutics to Present at Upcoming Investor..
8/13/201906:02EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
8/09/201907:12EDGARCurrent Report Filing (8-k)
8/09/201907:00PRNUSLeap Therapeutics Reports Second Quarter 2019 Financial..
8/09/201906:53EDGARQuarterly Report (10-q)
8/09/201906:01EDGARNotice of Effectiveness (effect)
8/06/201907:16EDGARCurrent Report Filing (8-k)
8/06/201907:00PRNUSLeap Presents Positive Clinical Results for the Combination..
7/31/201917:26EDGARSecurities Registration Statement (s-1)
7/25/201907:00PRNUSLeap Therapeutics to Host Conference Call to Provide DKN-01..
7/11/201908:18EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/11/201908:11EDGARCurrent Report Filing (8-k)
7/11/201908:00PRNUSLeap Therapeutics Announces Common Stock Purchase Agreements..
6/17/201908:47EDGARCurrent Report Filing (8-k)
6/12/201916:47EDGARStatement of Changes in Beneficial Ownership (4)
6/12/201916:46EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NASDAQ
LPTX
Leap Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.